KR101000963B1 - 캄토테신의 20 번 위치의 에스테르 - Google Patents

캄토테신의 20 번 위치의 에스테르 Download PDF

Info

Publication number
KR101000963B1
KR101000963B1 KR1020047016881A KR20047016881A KR101000963B1 KR 101000963 B1 KR101000963 B1 KR 101000963B1 KR 1020047016881 A KR1020047016881 A KR 1020047016881A KR 20047016881 A KR20047016881 A KR 20047016881A KR 101000963 B1 KR101000963 B1 KR 101000963B1
Authority
KR
South Korea
Prior art keywords
branched
alkyl
straight
camptothecin
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020047016881A
Other languages
English (en)
Korean (ko)
Other versions
KR20050036910A (ko
Inventor
마지마우로
알로아티도메니코
피사노클라우디오
틴티마리아오르넬라
베시로레다나
주니노프란코
Original Assignee
이스티튜토나치오날레페르로스튜디오에라쿠라데이투모리
시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이스티튜토나치오날레페르로스튜디오에라쿠라데이투모리, 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. filed Critical 이스티튜토나치오날레페르로스튜디오에라쿠라데이투모리
Publication of KR20050036910A publication Critical patent/KR20050036910A/ko
Application granted granted Critical
Publication of KR101000963B1 publication Critical patent/KR101000963B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
KR1020047016881A 2002-05-31 2003-05-28 캄토테신의 20 번 위치의 에스테르 Expired - Fee Related KR101000963B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM2002A000306 2002-05-31
IT2002RM000306A ITRM20020306A1 (it) 2002-05-31 2002-05-31 Esteri in posizione 20 di camptotecine.

Publications (2)

Publication Number Publication Date
KR20050036910A KR20050036910A (ko) 2005-04-20
KR101000963B1 true KR101000963B1 (ko) 2010-12-13

Family

ID=11456339

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020047016881A Expired - Fee Related KR101000963B1 (ko) 2002-05-31 2003-05-28 캄토테신의 20 번 위치의 에스테르

Country Status (21)

Country Link
US (2) US7452900B2 (enExample)
EP (2) EP1509529B1 (enExample)
JP (1) JP4593270B2 (enExample)
KR (1) KR101000963B1 (enExample)
CN (1) CN100376583C (enExample)
AR (1) AR040140A1 (enExample)
AT (1) ATE439362T1 (enExample)
AU (1) AU2003241161C1 (enExample)
CA (1) CA2487252C (enExample)
CY (2) CY1109581T1 (enExample)
DE (1) DE60328777D1 (enExample)
DK (2) DK1509529T3 (enExample)
ES (2) ES2331569T3 (enExample)
IT (1) ITRM20020306A1 (enExample)
MX (1) MXPA04011681A (enExample)
PE (1) PE20040533A1 (enExample)
PL (1) PL374009A1 (enExample)
PT (2) PT1509529E (enExample)
SI (2) SI1509529T1 (enExample)
TW (1) TWI331151B (enExample)
WO (1) WO2003101996A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852606A1 (fr) * 2003-03-18 2004-09-24 Inst Nat Sante Rech Med Moyens pour inhiber simultanement l'expression de plusieurs genes impliques dans une pathologie
CN1946421B (zh) 2004-04-27 2013-07-17 威尔斯达特生物制剂公司 使用病毒和喜树碱进行的癌症治疗
ITRM20040242A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.
RU2435586C2 (ru) 2005-07-14 2011-12-10 Веллстат Байолоджикс Корпорейшн Лечение рака с применением вирусов, фторпиримидинов и камптотецинов
CN103864811A (zh) * 2012-12-13 2014-06-18 天津科技大学 一种新颖的10-羟基喜树碱20位衍生物制备方法及其在抗肿瘤药物中的应用
WO2014121033A1 (en) * 2013-02-04 2014-08-07 Fl Therapeutics Llc Soluble complexes of drug analogs and albumin
WO2015200837A1 (en) 2014-06-27 2015-12-30 Fl Therapeutics Llc Abiraterone derivatives and non-covalent complexes with albumin
WO2016065139A1 (en) 2014-10-24 2016-04-28 Fl Therapeutics Llc 3-substituted piperidine-2, 6-diones and non-covalent complexes with albumin
JP6877049B2 (ja) 2015-09-25 2021-05-26 ゼットワイ セラピューティクス インク．Ｚｙ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 多糖類−ビタミン共役体を含む粒状物に基づく薬物製剤
CN106279286B (zh) * 2016-08-12 2018-11-30 华中科技大学 一种喜树碱膦酸酯类化合物、其制备方法及应用
CN110577551A (zh) * 2018-06-08 2019-12-17 遵义医学院 喜树碱-甘氨酸-5,6-二溴去甲斑蝥素结合物及其应用
BR112022000401A2 (pt) 2019-07-11 2022-03-29 Sun Pharma Advanced Res Co Ltd Derivados de camptotecina com uma porção dissulfeto e uma porção piperazina
CN116514829A (zh) * 2020-08-21 2023-08-01 诺茗(北京)生物医药有限公司 一种水溶性抗肿瘤前药及其药物组合物和用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000053607A1 (en) * 1999-03-09 2000-09-14 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943579A (en) * 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JP3186166B2 (ja) * 1992-02-10 2001-07-11 ロンザ リミテッド サリチロイル−カルニチンおよびその製造方法
US5646159A (en) * 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
WO1997021865A1 (en) 1995-12-15 1997-06-19 The Dexter Corporation Abrasive nonwoven web and method of manufacture
PT1100589E (pt) 1998-07-30 2005-05-31 Sigma Tau Ind Farmaceuti Utilizacao de propionil-l-carnitina e acetil-l-carnitina na preparacao de medicamentos com actividade anticancerigena
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
DE19916945C1 (de) 1999-04-15 2000-10-05 Clariant Gmbh Aromatische Aldehydharze und ihre Verwendung als Emulsionsspalter
US6228855B1 (en) 1999-08-03 2001-05-08 The Stehlin Foundation For Cancer Research Aromatic esters of camptothecins and methods to treat cancers
US6288072B1 (en) * 1999-12-29 2001-09-11 Monroe E. Wall Camptothecin β-alanine esters with topoisomerase I inhibition
US6629995B1 (en) 2000-03-31 2003-10-07 Super Gen, Inc. Camptothecin conjugates

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000053607A1 (en) * 1999-03-09 2000-09-14 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity

Also Published As

Publication number Publication date
PT1509529E (pt) 2009-11-13
JP2005529935A (ja) 2005-10-06
MXPA04011681A (es) 2005-03-31
PT2112154E (pt) 2013-10-02
WO2003101996A3 (en) 2004-01-29
HK1079206A1 (en) 2006-03-31
US20050256148A1 (en) 2005-11-17
CA2487252C (en) 2010-08-10
SI2112154T1 (sl) 2013-12-31
US7452900B2 (en) 2008-11-18
AR040140A1 (es) 2005-03-16
WO2003101996A8 (en) 2004-04-29
CN100376583C (zh) 2008-03-26
ES2331569T3 (es) 2010-01-08
PL374009A1 (en) 2005-09-19
SI1509529T1 (sl) 2009-12-31
US20070213353A1 (en) 2007-09-13
CA2487252A1 (en) 2003-12-11
DK1509529T3 (da) 2009-12-14
KR20050036910A (ko) 2005-04-20
WO2003101996A2 (en) 2003-12-11
EP2112154A1 (en) 2009-10-28
CY1109581T1 (el) 2014-08-13
ITRM20020306A0 (it) 2002-05-31
ES2432379T3 (es) 2013-12-03
JP4593270B2 (ja) 2010-12-08
TWI331151B (en) 2010-10-01
TW200403246A (en) 2004-03-01
AU2003241161B2 (en) 2009-10-22
ITRM20020306A1 (it) 2003-12-01
EP1509529A2 (en) 2005-03-02
CN1656101A (zh) 2005-08-17
PE20040533A1 (es) 2004-08-26
DK2112154T3 (da) 2013-10-21
AU2003241161A1 (en) 2003-12-19
ATE439362T1 (de) 2009-08-15
CY1114692T1 (el) 2016-10-05
EP2112154B1 (en) 2013-07-24
EP1509529B1 (en) 2009-08-12
US7498340B2 (en) 2009-03-03
DE60328777D1 (en) 2009-09-24
AU2003241161C1 (en) 2010-03-04

Similar Documents

Publication Publication Date Title
US7498340B2 (en) Esters in position 20 of camptothecins
KR100191193B1 (ko) 6환 화합물
AU774174B2 (en) Camptothecin derivatives having antitumor activity
US5340817A (en) Method of treating tumors with anti-tumor effective camptothecin compounds
KR101042042B1 (ko) 변형된 락톤 고리를 갖는 캄토테신
WO1996041806A1 (en) Novel water-soluble fluoroethylcamptothecin derivative and process for production thereof
WO2012007619A1 (es) Proceso de obtención de derivados solubles en agua de 20(s)camptotecina como agentes antitumorales
US7105492B2 (en) Camptothecin derivatives having antitumor activity
CZ297896B6 (cs) Kamptothecin, farmaceutická kompozice s jeho obsahem a jeho pouzití
PL188075B1 (pl) Rozpuszczalne w wodzie C-pierścieniowe analogi 20(S)-kamptotecyny, kompozycja farmaceutyczna zawierająca te związki, ich zastosowanie oraz sposób wytwarzania
HK1079206B (en) Esters in position 20 of camptothecins
HK1031222B (en) Camptothecin derivatives having antitumor activity

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20131125

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20141124

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20151124

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

R17-X000 Change to representative recorded

St.27 status event code: A-5-5-R10-R17-oth-X000

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20161208

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20161208